[go: up one dir, main page]

GB9723078D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9723078D0
GB9723078D0 GBGB9723078.3A GB9723078A GB9723078D0 GB 9723078 D0 GB9723078 D0 GB 9723078D0 GB 9723078 A GB9723078 A GB 9723078A GB 9723078 D0 GB9723078 D0 GB 9723078D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9723078.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand UK Research Ltd
Original Assignee
Cerebrus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerebrus Ltd filed Critical Cerebrus Ltd
Priority to GBGB9723078.3A priority Critical patent/GB9723078D0/en
Publication of GB9723078D0 publication Critical patent/GB9723078D0/en
Priority to EP98950227A priority patent/EP1027335A1/en
Priority to JP2000518950A priority patent/JP2001521924A/en
Priority to PCT/GB1998/003244 priority patent/WO1999023075A1/en
Priority to AU96380/98A priority patent/AU9638098A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
GBGB9723078.3A 1997-10-31 1997-10-31 Chemical compounds Ceased GB9723078D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9723078.3A GB9723078D0 (en) 1997-10-31 1997-10-31 Chemical compounds
EP98950227A EP1027335A1 (en) 1997-10-31 1998-10-30 Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents
JP2000518950A JP2001521924A (en) 1997-10-31 1998-10-30 Ortho-hydroxypyridinone derivatives as iron chelators and antioxidants
PCT/GB1998/003244 WO1999023075A1 (en) 1997-10-31 1998-10-30 Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents
AU96380/98A AU9638098A (en) 1997-10-31 1998-10-30 Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9723078.3A GB9723078D0 (en) 1997-10-31 1997-10-31 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9723078D0 true GB9723078D0 (en) 1998-01-07

Family

ID=10821419

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9723078.3A Ceased GB9723078D0 (en) 1997-10-31 1997-10-31 Chemical compounds

Country Status (5)

Country Link
EP (1) EP1027335A1 (en)
JP (1) JP2001521924A (en)
AU (1) AU9638098A (en)
GB (1) GB9723078D0 (en)
WO (1) WO1999023075A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1006108A1 (en) * 1998-12-01 2000-06-07 Cerebrus Pharmaceuticals Limited 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers
EP1006112A1 (en) * 1998-12-01 2000-06-07 Cerebrus Pharmaceuticals Limited 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers
ES2421511T3 (en) 2001-12-21 2013-09-03 X Ceptor Therapeutics Inc LXR modulators
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
US6825204B2 (en) 2002-02-05 2004-11-30 Bristol-Myers Squibb Company N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
AU2003282337B2 (en) * 2002-11-07 2009-07-16 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
MX2012010188A (en) * 2010-03-04 2012-10-03 Merck Sharp & Dohme Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders.
CN110407741B (en) * 2018-04-26 2023-03-21 启元生物(杭州)有限公司 Anti-inflammatory compound and preparation and application thereof
CN111170936B (en) 2020-01-19 2021-01-01 杭州泽德医药科技有限公司 3,4-Dihydroxy-N-(1'-benzyl-2'-hydroxyethyl)-2-methylpyridine chloride and its preparation and application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US5336482A (en) * 1991-12-05 1994-08-09 The Du Pont Merck Pharmaceutical Company Technetium-99m complexes with N-substituted 3-hydroxy-4-pyridinones
US5624901A (en) * 1994-04-15 1997-04-29 The Regents Of The University Of California 3-hydroxy-2(1H)-pyridinone chelating agents
ATE299135T1 (en) * 1995-09-29 2005-07-15 Novartis Pharma Gmbh HYDROXYPYRIDINONE
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease

Also Published As

Publication number Publication date
EP1027335A1 (en) 2000-08-16
JP2001521924A (en) 2001-11-13
WO1999023075A1 (en) 1999-05-14
AU9638098A (en) 1999-05-24

Similar Documents

Publication Publication Date Title
GB9705361D0 (en) Chemical compounds
GB9704208D0 (en) Chemical compounds
GB9717804D0 (en) Chemical compounds
GB9708530D0 (en) Chemical compounds
GB9723078D0 (en) Chemical compounds
GB9703201D0 (en) Chemical compounds
GB9708119D0 (en) Chemical compounds
GB9706707D0 (en) Chemical compounds
GB9715768D0 (en) Chemical compounds
GB9711994D0 (en) Chemical compounds
GB9713731D0 (en) Chemical compounds
GB9702998D0 (en) Chemical compounds
GB9704182D0 (en) Chemical compounds
GB9717279D0 (en) Chemical compounds
GB9717796D0 (en) Chemical compounds
GB9713490D0 (en) Chemical compounds
GB9713410D0 (en) Chemical compounds
GB9712270D0 (en) Chemical compounds
GB9701305D0 (en) Chemical compounds
GB9711712D0 (en) Chemical compounds
GB9717795D0 (en) Chemical compounds
GB9717794D0 (en) Chemical compounds
GB9711708D0 (en) Chemical compounds
GB9711143D0 (en) Chemical compounds
GB9716961D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)